Risk of testicular germ cell tumors and polymorphisms in the insulin-like growth factor genes

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 3, 2008, Pages 721-726

  Chia, Victoria M ^a   Sakoda, Lori C ^b   Graubard, Barry I ^a   Rubertone, Mark V ^c   Chanock, Stephen J ^a   Erickson, Ralph L ^d   McGlynn, Katherine A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c US Army Center for Health Promotion and Preventive Medicine   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GERM CELL TUMOR; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; BODY HEIGHT; HAPLOTYPES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RISK; TESTICULAR NEOPLASMS;

EID: 41549153020     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0768     Document Type: Article

References (25)

1. McGlynn KA. Environmental and host factors in testicular germ cell tumors. Cancer Invest 2001;19:842-53.
2. McGlynn KA, Sakoda LC, Rubertone MV, et al. Body size, dairy consumption, puberty, and risk of testicular germ cell tumors. Am J Epidemiol 2007;165:355-63.
3. Rasmussen F, Gunnell D, Ekbom A, Hallqvist J, Tynelius P. Birth weight, adult height, and testicular cancer: cohort study of 337,249 Swedish young men. Cancer Causes Control 2003;14:595-8.
4. Richiardi L, Askling J, Granath F, Akre O. Body size at birth and adulthood and the risk for germ-cell testicular cancer. Cancer Epidemiol Biomarkers Prev 2003;12:669-73.
5. Zavos C, Andreadis C, Diamantopoulos N, Mouratidou D. A hypothesis on the role of insulin-like growth factor I in testicular germ cell tumours. Med Hypotheses 2004;63:511-4.
6. Lackey BR, Gray SL, Henricks DM. The insulin-like growth factor (IGF) system and gonadotropin regulation: actions and interactions. Cytokine Growth Factor Rev 1999;10:201-17.
7. Parrizas M, LeRoith D. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 1997;138:1355-8.
8. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
9. Al-Zahrani A, Sandhu MS, Luben RN, et al. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 2006;15:1-10.
10. Johnston LB, Dahlgren J, Leger J, et al. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. J Clin Endocrinol Metab 2003;88:4805-10.
11. Wong HL, Delellis K, Probst-Hensch N, et al. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore Chinese. Cancer Epidemiol Biomarkers Prev 2005;14:144-51.
12. Canzian F, McKay JD, Cleveland RJ, et al. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 2006;94:299-307.
13. Cheng I, Stram DO, Penney KL, et al. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort. J Natl Cancer Inst 2006;98:123-34.
14. Rogers I, Metcalfe C, Gunnell D, Emmett P, Dunger D, Holly J. Insulin-like growth factor-I and growth in height, leg length, and trunk length between ages 5 and 10 years. J Clin Endocrinol Metab 2006;91:2514-9.
15. Packer BR, Yeager M, Burdett L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 2006;34:D617-21.
16. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
17. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-34.
18. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109-20S.
19. Colangelo LA, Liu K, Gapstur SM. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and cardiovascular disease risk factors in young Black men and White men: the CARDIA Male Hormone Study. Am J Epidemiol 2004;160:750-7.
20. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003;97:63-70.
21. Akman I, Arioglu P, Koroglu OA, et al. Maternal zinc and cord blood zinc, insulin-like growth factor-1, and insulin-like growth factor binding protein-3 levels in small-for-gestational-age newborns. Clin Exp Obstet Gynecol 2006;33:238-40.
22. Richiardi L, Pettersson A, Akre O. Genetic and environmental risk factors for testicular cancer. Int J Androl 2007;30:230-40.
23. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005;16:83-95.
24. Remes T, Vaisanen SB, Mahonen A, et al. Bone mineral density, body height, and vitamin D receptor gene polymorphism in middle-aged men. Ann Med 2005;37:383-92.
25. Remes T, Vaisanen SB, Mahonen A, et al. Aerobic exercise and bone mineral density in middle-aged Finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor alpha gene polymorphisms. Bone 2003;32:412-20.